Oxetanones
US5246960A · kind A · utility
29Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 1992 |
| Grant date | Sep 21, 1993 |
| Priority date | — |
| Expiry date | Sep 14, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Racemic compounds of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and n are as described herein, enantiomers and diastereomers thereof, and salts of these esters with weak acids, are described. These compounds inhibit pancreas lipase and are useful agents in the treatment of obesity, hyperlipaemia, atherosclerosis and arteriosclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.